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a b s t r a c t
Stat1 is a pivotal transcription factor for generation of the interferon (IFN)-dependent antiviral response.
Two Stat1 knockout mouse lines have been previously generated, one deleted the N-terminal domain
(ΔNTD) and one in the DNA-binding domain (ΔDBD). These widely-used strains are assumed
interchangeable, and both are highly susceptible to various pathogens. In this study, primary cells
derived from ΔNTD mice were shown to be signiﬁcantly more responsive to IFN, and established an
antiviral state with greater efﬁciency than cells derived from ΔDBD mice, following infection with
vesicular stomatitis virus and herpes simplex virus type-1. Also, while mice from both strains succumbed
rapidly and equally to virus infection,ΔDBD mice supported signiﬁcantly higher replication in brains and
livers than ΔNTD mice. Endpoint-type experimental comparisons of these mouse strains are therefore
misleading in failing to indicate important differences in virus replication and innate response.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Stat1 is a pivotal component of the signaling pathway for both
type I and type II interferons (IFNs) (O’Shea et al., 2011; Stark and
Darnell, 2012). For type I IFNs, IFNα and IFNβ, engagement with
their cognate receptor leads to phosphorylation of Stat1 and the
formation of a heterotrimeric complex of Stat1, Stat2 and ISGF3
which translocates to the nucleus to stimulate expression of genes
that contain IFN-stimulated response elements or ISREs (Schindler
et al., 2007). Engagement of type II IFN (IFNγ) with its cognate
receptor leads to formation of phosporylated Stat1 homodimers
that stimulate expression of genes downstream of gamma-
activated sequence (GAS) motifs (Lew et al., 1989). Collectively,
stimulation of ISRE- and GAS-containing genes leads to initiation
of the innate antiviral response and development of adaptive
immunity. In addition to its role in establishing the antiviral state
(Durbin et al., 1996; Meraz et al., 1996), Stat1 also plays a role in
growth arrest and apoptosis (Kumar et al., 1997), and cancer (Chan
et al., 2012; Hix et al., 2013). Most importantly, Stat1 is critical for
the control of virus infection in humans (Boisson-Dupuis et al.,
2012).
Two domains that are especially important for the function of
Stat1 are the N-terminal domain (NTD) which is necessary for
homo- and hetero-dimerization of the protein (Vinkemeier et al.,
1996), and the DNA-binding domain (DBD) that is required for its
function as a site-speciﬁc transcription factor (Schindler et al.,
1995). Both of these domains have been deleted in the context of
knockout mouse strains (Durbin et al., 1996; Meraz et al., 1996)
and these two lines have been used extensively in literally
hundreds of studies of signal transduction in innate immunity,
innate immunity to bacterial and viral pathogens, and tumorigen-
esis (see for example Bente et al., 2010; Hofer et al., 2012;
Khodarev et al., 2004; Klover et al., 2010). These mouse lines have
been used and interpreted more or less interchangeably since their
separate development in 1996, and in their respective initial
characterizations both lines were highly susceptible to vesicular
stomatitis virus (VSV) infection. In 2005, a study using both Stat1-
deﬁciant mouse lines concluded that both lines were relatively
resistant to dengue virus infection relative to IFNαβγR / mice
(Shresta et al., 2005). That study reported that mice lacking the
NTD were capable of making IFNα in response to virus infection
and concluded that Stat1-independent mechanisms were respon-
sible. A subsequent study showed that while both Stat1-deﬁcient
mice were very susceptible to lethal infection, HSV-1 was neuro-
tropic in the NTD-deﬁcient line (ΔNTD), but viscerotropic in
the DBD-deﬁcient line (ΔDBD), with signiﬁcant involvement of
the liver (Pasieka et al., 2011). This and another study has led to
the suggestion that the ΔNTD may have a small amount of
residual Stat1-activity (Bowick et al., 2012). An important caveat
of the previous HSV study, however, was that HSV is resistant to
IFN, encoding multiple genes that inhibit IFN responses and Stat1
signaling (for example ICP0, ICP34.5 and vhs, Halford et al., 2006;
Leib et al., 2000; Pasieka et al., 2008). This complicates the overall
interpretation of the data with HSV since these genes may
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function with differential efﬁcacy against residual Stat1 activity.
Moreover, the direct comparison of ΔNTD and ΔDBD mice was
limited to a bioluminescence imaging analysis of increased viral
hepato-tropism in ΔDBD mice, with no analyses of IFN responses,
comparative replication, or mortality performed.
In the present study, we therefore directly compared the replica-
tion of HSV in parallel with VSV, an IFN-sensitive virus, in primary
ﬁbroblasts derived from ΔNTD and ΔDBD mice. This approach also
allows us to directly compare the susceptibility of ΔNTD and ΔDBD
mice to both RNA and DNA viruses. We examined the response of
these ﬁbroblasts to IFN and also assessed HSV and VSV pathogenesis
in both mouse strains. Our study revealed that despite signiﬁcant
differences in the abilities of ΔNTD and ΔDBD ﬁbroblasts to respond
to IFN and control VSV and HSV replication in vitro, and clear
differences in viral replication in vivo, both strains of mice are highly
and equally susceptible to VSV and HSV as judged by endpoint
analyses. These data show that despite the ability of primary cells
derived fromΔNTD mice to respond to IFN and partially control virus
replication, these partial IFN responses are insufﬁcient to substantially
alter VSV- and HSV-induced mortality. The comparability of these two
Stat1-deﬁcient strains is therefore dependent upon experimental
system and virus, and future and previous virological data from these
two mouse strains must be carefully interpreted and compared.
Results
VSV and HSV-1 replicate with signiﬁcantly reduced efﬁciency in IFN-
treated primary MEFs derived from ΔNTD relative to ΔDBD mice
Monolayers of primary MEFs derived from control, ΔNTD and
ΔDBD mice were treated overnight with varying doses of IFNβ,
and subsequently infected with VSV at an MOI 0.01, and mono-
layers harvested and titered at 12 h post-infection (Fig. 1A). In the
absence of IFN treatment, all three lines yielded equivalent levels
of VSV at 12 h, suggesting that at this timepoint endogenous IFN
synthesis was insufﬁcient to control VSV. Pre-treatment with as
little as 0.2 U/ml of IFNβ, however, led to a 450-fold (po0.05)
lower yield of VSV fromΔNTD relative toΔDBD MEFs. Yields from
control MEFs decreased signiﬁcantly in a dose-dependent fashion
as IFN levels were increased, reaching a nadir at 0.2 U/ml. Yields
from ΔNTD MEFs were not changed signiﬁcantly with increasing
IFN treatment until a concentration of 10 U/ml was used, resulting
in a 41000-fold reduction in VSV titers (po0.0001) relative to
untreated MEFs. In contrast, yields from ΔDBD MEFs were not
changed with increasing IFN treatment up to 1 U/ml, with a non-
statistically signiﬁcant 8-fold reduction in titer at 10 U/ml of IFNβ.
Notably the control of VSV replication did not alter further in
ΔDBD MEFs even at a higher concentration of 100 U/ml (data not
shown). Taken together, these data demonstrate that ΔDBD and
ΔNTD MEFs differ signiﬁcantly from each other (po0.0001) in
their abilities to control VSV replication in response to IFN
treatment, with ΔNTD MEFs being more responsive to IFN than
ΔDBD. As expected, both Stat1/ strains were signiﬁcantly
less responsive to IFN than control MEFs. The rank order of
these MEFs to respond to IFN and control VSV replication,
(controlcΔNTD4ΔDBD) was recapitulated when infected with
HSV-1 strain KOS (Fig. 1B). Together, these data largely dispel the
hypothesis that it is the differential capability of HSV-1 to counter
any residual activity of the ΔNTD and ΔDBD Stat1 alleles that
results in disparate viral growth in these two mouse strains.
Rather, these data support the notion that it is simply the intrinsic
differential ability of these two mouse lines to respond to IFN that
results in unequal control of virus replication.
Fig. 1. (A) Titers of VSV 12 h postinfection from MEFs infected at MOI 0.01. MEFs (derived from control 129 mice, orΔDBD andΔNTD Stat1-deﬁcient mice) were pre-treated for
18 h with varying concentrations of IFNβ. (B) Titers of HSV-1 24 h postinfection from MEFs infected at MOI 0.01 pretreated for 18 h with varying concentrations of IFNβ. (C) Real-
time PCR analysis using the 2ΔΔCT method for IFIT1 transcript 6 h post-treatment with indicated amounts of IFNβ. Data shown for each panel are derived from two or more
independent experiments performed in duplicate. Dashed lines indicate the limit of detection, * and § indicate datasets that are statistically signiﬁcantly different from untreated
controls (po0.05Z0.004). Data shown in panels (A) and (B) are averaged from a minimum of two experiments performed in duplicate, or in panel (C) in triplicate.
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IFN-treated primary MEFs derived from ΔNTD relative to ΔDBD mice
differentially up-regulate IFIT1
To further address the hypothesis that ΔNTD and ΔDBD mice
differ in their ability to respond to IFN, we measured ISG gene
expression in response to IFN treatment in the absence of viral
infection. We used IFIT1 as a representative ISG since it is strongly
up-regulated by IFN in a Stat1-dependent fashion (Bluyssen et al.,
1994). At all concentrations of IFN used, MEFs derived from
129SVEV mice responded strongly (Fig. 1C). Indeed, addition of
1 U/ml of IFNβ appeared sufﬁcient to saturate the induction of
IFIT1. In contrast, the addition of IFN induced a dose-dependent
increase in IFIT1 expression from MEFs derived from both ΔNTD
and ΔDBD mice. Interestingly, and in concordance with the VSV
and HSV growth data (Fig. 1A and B), induction of IFIT1 was higher
in the ΔNTD MEFs relative to ΔDBD. Furthermore, despite an
overall lower trend, the induction of IFIT1 RNA inΔNTD MEFs was
statistically indistinguishable from 129SVEV following treatment
with 10 and 100 U/ml IFNβ. Together, these data show that
primary cells derived from ΔNTD and ΔDBD mice differ signiﬁ-
cantly at the level of control of virus replication and ISG induction.
ΔNTD and ΔDBD mice exhibit equivalent susceptibility to VSV
The results above showing differential replication of VSV and
HSV-1 in ΔNTD and ΔDBD MEFs led us to speculate whether the
rank order of resistance (controlcΔNTD4ΔDBD) would recapi-
tulate in vivo. The original publications describing ΔNTD and
ΔDBD mice showed high mortality following VSV infection for
both strains compared to controls (Durbin et al., 1996; Meraz et al.,
1996), but no direct or quantitative comparisons of the Stat1 /
mouse strains were performed. Several studies have shown that
ΔNTD mice are also highly susceptible to HSV-1, but direct
comparison to ΔDBD mice has been limited to a single study of
hepatotropism (Pasieka et al., 2011). We therefore wished to
compare these mice in more detail following infection with VSV
and HSV-1. We infected mice ip with 20 pfu VSV and measured
time for mice to reach to endpoint criteria, as well as assessing
titers in liver and brain on day 2, one day before the onset of
mortality (Fig. 2). There were signiﬁcantly higher VSV titers in
both the brains and livers of ΔDBD relative to ΔNTD and control
mice (po0.001), consistent with the in vitro data shown above
(Fig. 2A). Based on these replication data, we anticipated that the
ΔDBD mice would be more susceptible to VSV-induced mortality
than ΔNTD mice. Surprisingly, following ip infection with VSV
there was rapid and synchronous mortality observed in both
ΔNTD and ΔDBD mice at 3 days post-infection, while the wild-
type mice all survived out to the 21 day cutoff time point (Fig. 2B).
Given this early simultaneous VSV-induced mortality we postu-
lated that the 100 pfu inoculum might be too high to parse
differences between the mouse strains. We therefore infected
mice ip with a lowered dose of 20 pfu VSV and again examined
mortality (Fig. 2C). At this lower dose we observed a more step-
wise pattern of mortality, with survival of a total of 11/34 (32%)
ΔDBD mice, and 3/19 (16%)ΔNTD mice, with 7/7 (100%) of control
mice surviving. While Kaplan–Meier plots for both ΔNTD
Fig. 2. Replication and lethality of VSV and HSV in ΔDBD and ΔNTD mice. (A) VSV titers in brain and liver of control (129), ΔDBD and ΔNTD mice 2 days post ip infection
with 20 pfu of VSV. Data were collected from a tosttal of 42 mice over two experiments with a minimum of ﬁve mice per group.*¼statistically signiﬁcantly different from
ΔNTD (po0.001). (B) Time taken to reach endpoint mortality criteria for control (129),ΔDBD andΔNTD mice following ip infection with 100 pfu VSV. Data were collected
from a total of 16 mice (n¼7 for control, n¼5 for ΔDBD and n¼6 for ΔNTD). (C) Time taken to reach endpoint mortality criteria for control (129), ΔDBD and ΔNTD mice
following ip infection with 20 pfu VSV. Data were collected from a total of 16 mice (n¼7 for control, n¼34 for ΔDBD, n¼19 for ΔNTD). NS¼not statistically signiﬁcant.
(D) Time taken to reach endpoint mortality criteria for control (129), ΔDBD and ΔNTD mice following corneal infection with 2106 pfu/eye of HSV-1. Data were collected
from a total of 23 mice (n¼9 for control, n¼7 for ΔDBD, n¼7 for ΔNTD).
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and ΔDBD mice were signiﬁcantly different (p40.0001) from
control mice, they were not signiﬁcantly different from each other.
That stated, there was a non-signiﬁcant trend for ΔNTD to be more
susceptible to VSV infection relative to ΔDBD mice. This slight
change in susceptibility notwithstanding, these results were surpris-
ing given the signiﬁcantly greater replication of VSV in ΔDBD MEFs
relative to ΔNTD, and the higher titers in the livers and brains of
ΔDBD relative to ΔNTD mice. To examine this further we infected
mice with 2106 pfu/eye of KOS and monitored time to reach
endpoint criteria (Fig. 2D). Similar to the experiments using VSV,
there was no discernable difference betweenΔDBD andΔNTD mice
in their mortality following infection with HSV-1. This further
extends the idea that these mice are equivalent in terms of general
susceptibility to infection, regardless of the IFN sensitivity of the
pathogen, and despite demonstrable signiﬁcant differences in the
responses of primary cells to IFN.
Discussion
The data of this study underscore the complexity of interpretation
of data from knockout mouse models in general, and also further give
caution to making direct comparisons between these two Stat1/
mouse strains. The in vitro data described herein demonstrate that
MEFs derived from ΔDBD and ΔNTD mice respond differentially to
IFN in terms of their ability to control VSV, and HSV-1—two very
different viruses, especially with regard to their IFN sensitivities. HSV-1
encodes for several speciﬁc functions that interfere directly with Stat1
and the antiviral activities of IFN, and is generally resistant to IFN
(Mossman and Ashkar, 2005). While VSV does antagonize the type I
IFN response through blocking RNA export via the matrix protein
(Waibler et al., 2007), VSV remains highly susceptible to the effects of
IFN. Despite their differences in IFN sensitivity, both viruses replicate
with a similar pattern in ΔDBD and ΔNTD MEFs in the presence of
IFN. Importantly, this demonstrates that it is an inherent difference in
the ability of these Stat-deﬁcient cells to mount an antiviral response,
rather than a difference in the ability of these viruses to counter any
residual functions of ΔDBD and ΔNTD alleles. This conclusion is
further supported by the observation that the induction of IFIT1 RNA
synthesis by IFNβ treatment in the absence of virus infection, clearly
differs between primary cells derived from the two mouse strains.
Previous work eliminated the possibility that mouse background
account for the phenotypic disparity (Pasieka et al., 2011), so these
data thereby show formally that primary cells derived from these
mouse lines differ in their molecular and functional antiviral
responses. One additional caveat is that only ﬁbroblasts were exam-
ined, and it is possible that IFN-driven responses in ΔDBD andΔNTD
mice may also differ by cell type. The responses of each cell type must
therefore be determined empirically.
The relative equivalence in susceptibility to VSV of ΔDBD and
ΔNTD mice was surprising given the differences in VSV produc-
tion between the two mouse lines. This pattern of equivalent
lethality but non-equivalent viral replication, however, is not
exclusive to VSV, since HSV-1 also induced similar mortality in
these two mouse strains despite the disparate replication patterns
in vitro shown in this study, and in vivo (Pasieka et al., 2011). These
data suggest that the susceptibility of both strains to viral infection
is sufﬁciently high such that even relatively large differences in
viral titers in critical organs (such as liver and brain) do not
signiﬁcantly alter the timing with which these mice reach end-
point clinical criteria. It is likely that once the innate immune
response is compromised below a certain functional threshold
(as in ΔNTD), further compromise (as in ΔDBD) does not result in
further detectable susceptibility as judged by endpoint analysis
following a pathogenic challenge. This is consistent with data
showing that VSV kills 100% of Iﬁt2/ mice within 6 days
following intra-nasal infection of VSV regardless of input dose
(Fensterl et al., 2012). That study also showed that mortality and
viral titers were often not correlated for VSV. This also emphasizes
the relative crudeness of endpoint-type experiments, which
although informative, do not reveal underlying important differ-
ences in biology, tropism and pathogenesis. Another confounding
issue is route of infection, which likely also plays a critical role in
the relative susceptibilities of these mouse strains.
These Stat1-deﬁcient mouse lines created by Durbin et al. (1996)
andMeraz et al. (1996) have been used in awide variety of in vitro and
in vivo studies, with almost 600 citations of these original papers in
the primary literature. The data of this study show that for in vitro
experiments at least, data acquired from these two lines cannot be
directly compared. In addition, Stat1-independent effects should be
equivalent in both lines, so the data further support the idea that the
Stat1 mutation inΔDBD mice represents a more complete ablation of
Stat1 function than mutation in the ΔNTD strain. The ΔDBD strain,
therefore seems preferable for studies in which it is necessary for the
mice to lack any residual Stat1 activity which may confound inter-
pretation of the data. The ΔNTD strain, however, is a closer model of
human Stat1 insufﬁciency, since, humans deﬁcient in Stat1 andΔNTD
mice both succumb to HSV-1 encephalitis (Boisson-Dupuis et al., 2012;
Pasieka et al., 2009), whereas ΔDBD mice acquire fulminant hepatitis
(Pasieka et al., 2011). Clearly both mouse strains have strengths and
weaknesses for investigation of IFN-driven innate immunity to viruses,
but it is apparent that these mouse strains differ signiﬁcantly in terms
of their innate responses, regardless of virus type and IFN sensitivity.
Methods and materials
Cells, viruses, and animal infection procedures
Mouse embryo ﬁbroblast (MEF) cultures were generated from 129
Sv/Ev, and Stat1 / mice at embryonic day 15 and passaged once
before being plated for infection. MEFs were cultured in Dulbecco0s
modiﬁed Eagle0s medium supplemented with 10% fetal calf serum,
0.1 mM sodium pyruvate, 250 U/ml penicillin, 250 μg/ml streptomy-
cin, and 250 ng/ml amphotericin B. Isogenic MEFs were also utilized.
For multiple-step growth curves, cells were pretreated overnight with
the appropriate concentration of IFNβ (Sigma, St. Louis, MO), and cells
were infected at a multiplicity of infection (MOI) of 0.01. All titering
and viral stock preparation was performed on Vero cells as previously
described (Rader et al., 1993). The VSV used was strain Indiana, and
the HSV-1 strain was KOS. Mouse strains used (Durbin et al., 1996;
Meraz et al., 1996) included the control 129S6 as wild type mice
(Taconic Farms, Germantown, NY), 129S6 Stat1-deﬁcient mice lacking
the N-terminal domain (referred to here as ΔNTD or Stat1/–NTD),
and 129 Stat1-deﬁcient mice lacking the DNA binding domain
(referred to here as ΔDBD or Stat1 /DBD). Mice were genotyped
by PCR and housed in the barrier facility in the Center for Compara-
tive Medicine and Research at The Geisel School of Medicine at
Dartmouth and were infected intraperitoneally or corneally in the
biohazard facility between the ages of 6–8 weeks (Rader et al., 1993;
Strelow and Leib, 1995). Mice were dissected at appropriate times and
organs harvested and titered as previously described (Strelow and
Leib, 1995), and times to reaching of endpoint criteria recorded.
Sentinel mice were screened every 3 months and determined to be
negative for adventitious mouse pathogens, in particular mouse
norovirus. Mice were housed, infected, and euthanized when neces-
sary in accordance with all Federal and University policies.
Quantitative real-time PCR
MEFs from the three mouse strains were cultured as above
and were treated with IFNβ (0, 1, 10 or 100 U/ml) for 6 h, then
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RNA was collected using the RNeasy kit (Quiagen). The RNA was
treated with DNase (New England Biolabs, MA), and cDNA was
synthesized using the SuperScript III kit (Life Technologies) with
random hexamers (Promega, WI). For QPCR, SYBR Green (Life
Technologies, NY) was used with primers for IFIT1 (Fw: TGC TTT
GCG AAG GCT CTG AAA GTG, Rv: TGG ATT TAA CCG GAC AGC CTT
CCT, 200 nM) and GAPDH (GAPDH Fw: CAT CTT CCA GGA GCG AGA
TCC C Rv: CAA ATG AGC CCC AGC CTT CTC C 400 nM). IFIT1 values
were calculated by the 2ΔΔCT method (Livak and Schmittgen,
2001) normalized to GAPDH, and values for IFNβ-treated MEFs
were normalized to untreated MEFs of the same strain.
Acknowledgments
This study was supported by National Institutes of Health grant to
D.L. (RO1 EY10707 and by the Geisel School of Medicine Immunology
Program to SK. The project was also supported by P20RR016437 from
the National Center for Research Resources to Dartmouth.
References
Bente, D.A., Alimonti, J.B., Shieh, W.J., Camus, G., Stroher, U., Zaki, S., Jones, S.M.,
2010. Pathogenesis and immune response of Crimean-Congo hemorrhagic fever
virus in a STAT-1 knockout mouse model. J. Virol. 84, 11089–11100.
Bluyssen, H.A., Vlietstra, R.J., Faber, P.W., Smit, E.M., Hagemeijer, A., Trapman, J.,
1994. Structure, chromosome localization, and regulation of expression of the
interferon-regulated mouse Iﬁ54/Iﬁ56 gene family. Genomics 24, 137–148.
Boisson-Dupuis, S., Kong, X.F., Okada, S., Cypowyj, S., Puel, A., Abel, L., Casanova, J.L.,
2012. Inborn errors of human STAT1: allelic heterogeneity governs the diversity
of immunological and infectious phenotypes. Curr. Opin. Immunol. 24,
364–378.
Bowick, G.C., Airo, A.M., Bente, D.A., 2012. Expression of interferon-induced
antiviral genes is delayed in a STAT1 knockout mouse model of Crimean-
Congo hemorrhagic fever. Virol. J. 9, 122.
Chan, S.R., Vermi, W., Luo, J., Lucini, L., Rickert, C., Fowler, A.M., Lonardi, S., Arthur,
C., Young, L.J., Levy, D.E., Welch, M.J., Cardiff, R.D., Schreiber, R.D., 2012. STAT1-
deﬁcient mice spontaneously develop estrogen receptor alpha-positive luminal
mammary carcinomas. Breast Cancer Res. BCR 14, R16.
Durbin, J.E., Hackenmiller, R., Simon, M.C., Levy, D.E., 1996. Targeted disruption of
the mouse Stat1 gene results in compromised innate immunity to viral disease.
Cell 84, 443–450.
Fensterl, V., Wetzel, J.L., Ramachandran, S., Ogino, T., Stohlman, S.A., Bergmann, C.C.,
Diamond, M.S., Virgin, H.W., Sen, G.C., 2012. Interferon-induced Iﬁt2/ISG54
protects mice from lethal VSV neuropathogenesis. PLoS Pathog. 8, e1002712.
Halford, W.P., Weisend, C., Grace, J., Soboleski, M., Carr, D.J., Balliet, J.W., Imai, Y.,
Margolis, T.P., Gebhardt, B.M., 2006. ICP0 antagonizes Stat 1-dependent
repression of herpes simplex virus: implications for the regulation of viral
latency. Virol. J. 3, 44.
Hix, L.M., Karavitis, J., Khan, M.W., Shi, Y.H., Khazaie, K., Zhang, M., 2013. Tumor
STAT1 transcription factor activity enhances breast tumor growth and immune
suppression mediated by myeloid-derived suppressor cells. J. Biol. Chem. 288,
11676–11688.
Hofer, M.J., Li, W., Manders, P., Terry, R., Lim, S.L., King, N.J., Campbell, I.L., 2012.
Mice deﬁcient in STAT1 but not STAT2 or IRF9 develop a lethal CD4þ T-cell-
mediated disease following infection with lymphocytic choriomeningitis virus.
J. Virol. 86, 6932–6946.
Khodarev, N.N., Beckett, M., Labay, E., Darga, T., Roizman, B., Weichselbaum, R.R.,
2004. STAT1 is overexpressed in tumors selected for radioresistance and
confers protection from radiation in transduced sensitive cells. Proc. Nat. Acad.
Sci. U.S.A. 101, 1714–1719.
Klover, P.J., Muller, W.J., Robinson, G.W., Pfeiffer, R.M., Yamaji, D., Hennighausen, L.,
2010. Loss of STAT1 from mouse mammary epithelium results in an increased
Neu-induced tumor burden. Neoplasia 12, 899–905.
Kumar, A., Commane, M., Flickinger, T.W., Horvath, C.M., Stark, G.R., 1997. Defective
TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels
of caspases. Science 278, 1630–1632.
Leib, D.A., Machalek, M.A., Williams, B.R., Silverman, R.H., Virgin, H.W., 2000.
Speciﬁc phenotypic restoration of an attenuated virus by knockout of a host
resistance gene. Proc. Nat. Acad. Sci. U.S.A. 97, 6097–6101.
Lew, D.J., Decker, T., Darnell Jr., J.E., 1989. Alpha interferon and gamma interferon
stimulate transcription of a single gene through different signal transduction
pathways. Mol. Cell. Biol. 9, 5404–5411.
Livak, K.J., Schmittgen, T.D., 2001. Analysis of relative gene expression data using
real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25,
402–408.
Meraz, M.A., White, J.M., Sheehan, K.C., Bach, E.A., Rodig, S.J., Dighe, A.S., Kaplan, D.
H., Riley, J.K., Greenlund, A.C., Campbell, D., Carver-Moore, K., DuBois, R.N.,
Clark, R., Aguet, M., Schreiber, R.D., 1996. Targeted disruption of the Stat1 gene
in mice reveals unexpected physiologic speciﬁcity in the JAK-STAT signaling
pathway. Cell 84, 431–442.
Mossman, K.L., Ashkar, A.A., 2005. Herpesviruses and the innate immune response.
Viral Immunol. 18, 267–281.
O’Shea, J.J., Gadina, M., Kanno, Y., 2011. Cytokine signaling: birth of a pathway.
J. Immunol. 187, 5475–5478.
Pasieka, T.J., Cilloniz, C., Lu, B., Teal, T.H., Proll, S.C., Katze, M.G., Leib, D.A., 2009. Host
responses to wild-type and attenuated herpes simplex virus infection in the
absence of Stat1. J. Virol. 83, 2075–2087.
Pasieka, T.J., Collins, L., O’Connor, M.A., Chen, Y., Parker, Z.M., Berwin, B.L., Piwnica-
Worms, D.R., Leib, D.A., 2011. Bioluminescent imaging reveals divergent viral
pathogenesis in two strains of Stat1-deﬁcient mice, and in alphassgamma
interferon receptor-deﬁcient mice. PLoS One 6, e24018.
Pasieka, T.J., Lu, B., Leib, D.A., 2008. Enhanced pathogenesis of an attenuated herpes
simplex virus for mice lacking Stat1. J. Virol. 82, 6052–6055.
Rader, K.A., Ackland-Berglund, C.E., Miller, J.K., Pepose, J.S., Leib, D.A., 1993. In vivo
characterization of site-directed mutations in the promoter of the herpes
simplex virus type 1 latency-associated transcripts. J. Gen. Virol. 74 (Pt 9),
1859–1869.
Schindler, C., Levy, D.E., Decker, T., 2007. JAK-STAT signaling: from interferons to
cytokines. J. Biol. Chem. 282, 20059–20063.
Schindler, U., Wu, P., Rothe, M., Brasseur, M., McKnight, S.L., 1995. Components of a
Stat recognition code: evidence for two layers of molecular selectivity.
Immunity 2, 689–697.
Shresta, S., Sharar, K.L., Prigozhin, D.M., Snider, H.M., Beatty, P.R., Harris, E., 2005.
Critical roles for both STAT1-dependent and STAT1-independent pathways in
the control of primary dengue virus infection in mice. J. Immunol. 175,
3946–3954.
Stark, G.R., Darnell Jr., J.E., 2012. The JAK-STAT pathway at twenty. Immunity 36,
503–514.
Strelow, L.I., Leib, D.A., 1995. Role of the virion host shutoff (vhs) of herpes simplex
virus type 1 in latency and pathogenesis. J. Virol. 69, 6779–6786.
Vinkemeier, U., Cohen, S.L., Moareﬁ, I., Chait, B.T., Kuriyan, J., Darnell Jr., J.E., 1996.
DNA binding of in vitro activated Stat1 alpha, Stat1 beta and truncated Stat1:
interaction between NH2-terminal domains stabilizes binding of two dimers to
tandem DNA sites. EMBO J. 15, 5616–5626.
Waibler, Z., Detje, C.N., Bell, J.C., Kalinke, U., 2007. Matrix protein mediated
shutdown of host cell metabolism limits vesicular stomatitis virus-induced
interferon-alpha responses to plasmacytoid dendritic cells. Immunobiology
212, 887–894.
S. Katzenell et al. / Virology 450-451 (2014) 350–354354
